The role of inhibitory pathways in petit mal epilepsy.
D000200:Action Potentials; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use*; D002220:Carbamazepine / Q000627:therapeutic use; D002415:Cats; D002540:Cerebral Cortex / Q000503:physiopathology; D004558:Electric Stimulation; D004832:Epilepsy, Absence / Q000188:drug therapy* / Q000503:physiopathology; D005013:Ethosuximide / Q000627:therapeutic use; D008442:Maxillary Nerve; D009433:Neural Inhibition / Q000187:drug effects; D010672:Phenytoin / Q000627:therapeutic use; D009435:Synaptic Transmission / Q000187:drug effects*; D014276:Trigeminal Nerve / Q000187:drug effects / Q000503:physiopathology; D014293:Trimethadione / Q000627:therapeutic use
D000927:Anticonvulsants; D002220:Carbamazepine; D005013:Ethosuximide; D010672:Phenytoin; D014293:Trimethadione